July 25, 2024Researchers in George Mason’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for lifelong medications.
February 22, 2023Through a grant from the National Institute of Minority Health and Health Disparities, Assistant Professor Rodman Turpin aims to reduce internalized racism, homophobia, and related stigma to increase the use of HIV pre-exposure prophylaxis (PrEP) among Black sexual minority men.